Literature DB >> 8621710

Inactivation of raf-1 by a protein-tyrosine phosphatase stimulated by GTP and reconstituted by Galphai/o subunits.

P Dent1, D B Reardon, S L Wood, M A Lindorfer, S G Graber, J C Garrison, D L Brautigan, T W Sturgill.   

Abstract

A membrane-associated form of Raf-1 in v-Ras transformed NIH 3T3 cells can be inactivated by protein phosphatases regulated by GTP. Herein, a distinct protein-tyrosine phosphatase (PTPase) in membrane preparations from v-Ras transformed NIH 3T3 cells was found to be activated by guanyl-5'-yl imidodiphosphate (GMPPNP) and was identified as an effector for pertussis toxin (PTx)-sensitive G-protein alpha subunits. PTPase activation was blocked by prior treatment of cells with PTx. PTPase activation by GTP, but not GMPPNP, was transient. A GMPPNP-stimulated PTPase (PTPase-G) co-purified with Galphai/o subunits during Superose 6 and Mono Q chromatography. PTPase-G activity in Superose 6 fractions from GDP-treated membranes was reconstituted by activated Galphai/o, but not G beta gamma, subunits. PTPase-G may contribute to GMPPNP-stimulated inactivation of Raf-1 in v-Ras cell membranes because Raf-1 inactivation was PTx-sensitive and PTPase-G inactivated exogenous Raf-1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621710     DOI: 10.1074/jbc.271.6.3119

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Activation of a protein tyrosine phosphatase and inactivation of Raf-1 by somatostatin.

Authors:  D B Reardon; S L Wood; D L Brautigan; G I Bell; P Dent; T W Sturgill
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

2.  Tyrosine phosphorylation of the proto-oncoprotein Raf-1 is regulated by Raf-1 itself and the phosphatase Cdc25A.

Authors:  K Xia; R S Lee; R P Narsimhan; N K Mukhopadhyay; B G Neel; T M Roberts
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

3.  Negative regulation of Raf-1 by phosphorylation of serine 621.

Authors:  H Mischak; T Seitz; P Janosch; M Eulitz; H Steen; M Schellerer; A Philipp; W Kolch
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

Review 4.  Membrane phospholipids, EML4-ALK, and Hsp90 as novel targets in lung cancer treatment.

Authors:  Andrei Laszlo; Dinesh Thotala; Dennis E Hallahan
Journal:  Cancer J       Date:  2013 May-Jun       Impact factor: 3.360

5.  The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo.

Authors:  Laurence Booth; Jane L Roberts; Cindy Sander; John Lee; John M Kirkwood; Andrew Poklepovic; Paul Dent
Journal:  Oncotarget       Date:  2017-03-07

Review 6.  Impact of oxidative stress on signal transduction control by phosphotyrosine phosphatases.

Authors:  C M Krejsa; G L Schieven
Journal:  Environ Health Perspect       Date:  1998-10       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.